CLINICAL_TRIALS trial_result · 2013-05-06

Clinical Trial Update: Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy [Phase 3]

This is a Phase 3 trial update evaluating misoprostol for treating fetal death at 14-28 weeks. The study has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Gynuity Health Projects | Conditions: Intrauterine Fetal Demise | Phase 3 | Status: COMPLETED | Results posted: 2013-05-06